Previous studies have demonstrated IHC 0/1+ breast cancers with HER-2 gene amplification as well as IHC 3+ cases without gene amplification [7]; [10]–[12]; [15]–[19]. This evidence concerns the gene ERBB2 and breast carcinoma.